---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-019817"
form_type: "8-K"
ticker: "PURE"
cik: "0001006028"
company_name: "PURE BIOSCIENCE, INC."
filed_at: "2022-07-19T23:59:59+00:00"
generated_at: "2026-06-24T11:58:08.433537+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PURE Bioscience raises $3.5M in private placement; CEO and directors participate

## Summary
- Raised $3.5M via private placement of 23,333,332 shares at $0.15/share.
- CEO Tom Y. Lee invested $3.26M through affiliates; directors Chen and Rendall invested $93,750 combined.
- Proceeds for general corporate purposes including R&D, admin, working capital.
- Shares issued under exemption from registration (Section 4(a)(2) and Rule 506).
- Disinterested board members approved the transaction.

## SEC filing metadata
- accession: 0001493152-22-019817
- form_type: 8-K
- ticker: PURE
- cik: 0001006028
- company_name: PURE BIOSCIENCE, INC.
- filed_at: 2022-07-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006028/000149315222019817/0001493152-22-019817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006028/000149315222019817/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-019817
- JSON: https://secwatch.observer/filing/0001493152-22-019817.json
- Plain text: https://secwatch.observer/filing/0001493152-22-019817.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.